ADARx Pharmaceuticals, Inc. (ADRX): Form 8-K filed 2026-11-12
- Accepted by EDGAR
- 2026-11-12 16:05 ET
- Event date
- 2026-11-12
- Accession no.
- 0001193125-26-458321
- Original filing
- SEC EDGAR filing index
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | adrx-20261112.htm |
| EX-99.1 | EX-99.1 | adrx-ex99_1.htm |
| EX-99.2 | EX-99.2 | adrx-ex99_2.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.